看好2026年，安捷伦公布Q1财报

Core Insights - Agilent reported Q1 2026 revenue of $1.8 billion, a 7% increase year-over-year, with core growth at 4.4% [1][2] - Non-GAAP earnings per share (EPS) reached $1.36, reflecting a 4% increase compared to the same period last year [1][2] - The company raised its full-year revenue guidance to a range of $7.3 billion to $7.5 billion [1] Financial Highlights by Business Segment - Life Sciences and Diagnostics segment (LDG) generated $679 million in revenue, a 5% increase year-over-year, with a core growth of 3% and an operating margin of 16% [3] - CrossLab segment (ACG) achieved $758 million in revenue, a 9% increase year-over-year, with core growth of 6% and an operating margin of 31.6% [4] - The third segment reported $361 million in revenue, a 7% increase year-over-year, with core growth of 4% and an operating margin of 25.8% [5] Full-Year and Q2 2026 Outlook - For the full fiscal year 2026, revenue is expected to be in the range of $7.3 billion to $7.5 billion, representing a year-over-year growth of 5.5% to 7.5%, with core growth of 4% to 6% [6] - Q2 2026 revenue is projected to be between $1.79 billion and $1.82 billion, indicating a year-over-year growth of approximately 7% to 9%, with core growth of 4% to 5.5% [6]